ArticleACS nano2025
High Specific Real-Time Tracking of Single Virus Particles.
Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Modulation of Presynaptic Inhibitory Retinal Circuits for Retinal Ganglion Cell Neuroprotection in Glaucoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Nondestructive tracking of viral infections by viral protein-initiated fluorescent sensors.Journal of virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Viruses are powerful biological platforms with broad applications in gene therapy, vaccine delivery, neuroscience, and nanomedicine. Unlocking their full potential requires a precise understanding of their dynamic behaviors, such as cellular entry, intracellular trafficking, and genome release, at the single-particle level. However, real-time tracking remains challenging due to the nanoscale size and optical transparency of viral particles, as well as limitations in current fluorescent labeling strategies. Conventional approaches using organic dyes or quantum dots (QDs) are often hindered by nonspecific background signals arising from unbound fluorophores. Here, we introduce a carbon quantum dot-virus association strategy that labels viral particles during their native assembly and packaging, thereby avoiding the limitations of postsynthetic modification. Through the integration of density gradient ultracentrifugation and size-selective filtration, we obtain highly purified, traceable viral particles devoid of detectable free QDs. Using adeno-associated virus (AAV) as nonenveloped virus models and lentivirus as enveloped ones, we demonstrate real-time tracking of viral entry, intracellular dynamics, and in vivo gene delivery to ocular tissues. This carbon QD-enabled platform presents single-particle spatiotemporal resolution and signal clarity, supporting high-fidelity viral imaging and next-generation viral therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.